系统性肥大细胞增多症累及胃壁致18F-FDG PET/CT弥漫性胃摄取
Diffuse Gastric Uptake on 18 F-FDG PET/CT Caused by Involvement of Mastocytosis in a Patient With Systemic Mastocytosis.
PubMed 文献 · Clin Nucl Med · 2025-09-11
一名65岁男性系统性肥大细胞增多症伴相关血液肿瘤(SM-AHN,合并浆细胞骨髓瘤)患者行18F-FDG PET/CT分期,除典型骨髓和脾脏摄取外,胃壁见弥漫性18F-FDG摄取,提示骨髓瘤或肥大细胞增多症累及;胃镜活检组织病理学证实为肥大细胞增多症累及。
要点
- SM-AHN患者18F-FDG PET/CT除骨髓和脾脏摄取外,胃壁弥漫性摄取可提示肥大细胞增多症累及。
- 胃壁弥漫性摄取需鉴别骨髓瘤或肥大细胞增多症累及,胃镜活检可确诊。
- 该病例经胃镜活检组织病理学证实为肥大细胞增多症胃累及。
核心结论
- SM-AHN患者胃壁弥漫性18F-FDG摄取可由肥大细胞增多症累及所致,经胃镜活检组织病理学证实。
研究设计与样本
- 65岁男性SM-AHN(合并浆细胞骨髓瘤)患者,行18F-FDG PET/CT分期及胃镜活检组织病理学分析。
主要发现
- 18F-FDG PET/CT示典型骨髓和脾脏摄取,并见胃壁弥漫性18F-FDG摄取,提示骨髓瘤或肥大细胞增多症累及。
- 胃镜活检组织病理学证实为肥大细胞增多症累及。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 65-year-old man with systemic mastocytosis and associated hematological neoplasm (plasma cell myeloma, SM-AHN) received an 18 F-FDG PET/CT for staging. In addition to the typical bone marrow and splenic uptake, PET/CT also showed diffuse 18 F-FDG uptake in the gastric wall. It suggested the involvement of myeloma or mastocytosis. Subsequent histopathologic analysis of gastric biopsy specimens through endoscopy confirmed the diagnosis of mastocytosis involvement.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Zhao Y, Wu Y, Su M, et al. Diffuse Gastric Uptake on 18 F-FDG PET/CT Caused by Involvement of Mastocytosis in a Patient With Systemic Mastocytosis. Clin Nucl Med. 2025. PMID: 40938150. doi:10.1097/RLU.0000000000006134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。